CLINICAL_TRIALS
trial_result
· 2010-08-04
Clinical Trial Update: Retapamulin Versus Placebo in Secondarily-Infected Traumatic Lesions (SITL) [Phase 3]
Summary
Phase 3 trial comparing retapamulin to placebo for secondarily infected traumatic skin lesions; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Skin Infections, Bacterial | Phase 3 | Status: COMPLETED | Results posted: 2010-08-04